AAAAAA

   
Results: 1-25 | 26-33 |
Results: 26-33/33
Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular- A report from the Children's Cancer Group
Authors: Umehara, S Nakagawa, A Matthay, KK Lukens, JN Seeger, RC Stram, DO Gerbing, RB Shimada, H
Citation: S. Umehara et al., Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular- A report from the Children's Cancer Group, CANCER, 89(5), 2000, pp. 1150-1161
Increase of ceramide and induction of mixed apoptosis necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines
Authors: Maurer, BJ Metelitsa, LS Seeger, RC Cabot, MC Reynolds, CP
Citation: Bj. Maurer et al., Increase of ceramide and induction of mixed apoptosis necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines, J NAT CANC, 91(13), 1999, pp. 1138-1146
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival
Authors: DuBois, SG Kalika, Y Lukens, JN Brodeur, GM Seeger, RC Atkinson, JB Haase, GM Black, CT Perez, C Shimada, H Gerbing, R Stram, DO Matthay, KK
Citation: Sg. Dubois et al., Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival, J PED H ONC, 21(3), 1999, pp. 181-189
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas
Authors: Guo, C White, PS Weiss, MJ Hogarty, MD Thompson, PM Stram, DO Gerbing, R Matthay, KK Seeger, RC Brodeur, GM Maris, JM
Citation: C. Guo et al., Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas, ONCOGENE, 18(35), 1999, pp. 4948-4957
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid
Authors: Matthay, KK Villablanca, JG Seeger, RC Stram, DO Harris, RE Ramsay, NK Swift, P Shimada, H Black, CT Brodeur, GM Gerbing, RB Reynolds, CP
Citation: Kk. Matthay et al., Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid, N ENG J MED, 341(16), 1999, pp. 1165-1173
The plasminogen-plasminogen activator (PA) system in neuroblastoma: Role of PA inhibitor-1 in metastasis
Authors: Sugiura, Y Ma, LQ Sun, B Shimada, H Laug, WE Seeger, RC DeClerck, YA
Citation: Y. Sugiura et al., The plasminogen-plasminogen activator (PA) system in neuroblastoma: Role of PA inhibitor-1 in metastasis, CANCER RES, 59(6), 1999, pp. 1327-1336
Hormone and fertility drug use and the risk of neuroblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group
Authors: Olshan, AF Smith, J Cook, MN Grufferman, S Pollock, BH Stram, DO Seeger, RC Look, AT Cohn, SL Castleberry, RP Bondy, ML
Citation: Af. Olshan et al., Hormone and fertility drug use and the risk of neuroblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group, AM J EPIDEM, 150(9), 1999, pp. 930-938
Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy
Authors: Keshelava, N Seeger, RC Groshen, S Reynolds, CP
Citation: N. Keshelava et al., Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy, CANCER RES, 58(23), 1998, pp. 5396-5405
Risultati: 1-25 | 26-33 |